TSX-V:LSL-DB - TSX Venture Exchange - - Currency: CAD
TSX-V:LSL-DB (5/6/2025, 7:00:00 PM)
100
0 (0%)
The current stock price of LSL-DB.CA is 100 CAD.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
JWEL.CA | JAMIESON WELLNESS INC | 21.06 | 1.41B | ||
LOVE.CA | CANNARA BIOTECH INC | 8.87 | 121.60M | ||
HILL.CA | HILL STREET BEVERAGE CO INC | N/A | 557.60K |
LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid and liquid dosage forms. The company specializes in the manufacturing and marketing of natural health products (NHPs). The firm manufactures a range of NHPs in liquid, powder and capsule form, sold under its own brand or under private labels. Its manufacturing activities include blistering, encapsulation, sachet and jar filling. The firm also owns Dermolab Pharma Ltd., a contract manufacturing company that specializes in the development, manufacturing and packaging of liquid and semi-solid cosmetic, pharmaceutical and natural health products. The company serves both the Canadian and international markets. The firm's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Virage Sante Inc.
LSL Pharma Group Inc
540, rue d'Avaugour, Office 1800
Boucherville QUEBEC CA
Employees: 114
Phone: 14506817744
The current stock price of LSL-DB.CA is 100 CAD.
The exchange symbol of LSL Pharma Group Inc is LSL-DB and it is listed on the TSX Venture Exchange exchange.
LSL-DB.CA stock is listed on the TSX Venture Exchange exchange.
LSL Pharma Group Inc (LSL-DB.CA) has a market capitalization of 11.55B CAD. This makes LSL-DB.CA a Large Cap stock.
LSL Pharma Group Inc (LSL-DB.CA) currently has 114 employees.
LSL Pharma Group Inc (LSL-DB.CA) has a support level at 99.99 and a resistance level at 100.01. Check the full technical report for a detailed analysis of LSL-DB.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LSL-DB.CA does not pay a dividend.
LSL Pharma Group Inc (LSL-DB.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
ChartMill assigns a technical rating of 2 / 10 to LSL-DB.CA.
ChartMill assigns a fundamental rating of 1 / 10 to LSL-DB.CA. LSL-DB.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months LSL-DB.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -17.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.37% | ||
ROE | -8.14% | ||
Debt/Equity | 0.45 |